Steve Flinkenstein, DO
Rheumatology · Hollywood, FLNPI 1821209255
Payments from drug & device makers
Across 117 payments — averaging $17.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$288
- Amgen$287
- Mallinckrodt Hospital Products Inc.$228
- Pfizer$217
- AbbVie$194
- ANI Pharmaceuticals, Inc.$151
- plus $670 from 14 others
What the payments were for
- Food & beverage$1,87792%
- Education$1578%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 11 | $288 |
| Amgen(2 entities) | 18 | $287 |
| Mallinckrodt Hospital Products Inc. | 17 | $228 |
| Pfizer | 22 | $217 |
| AbbVie | 9 | $194 |
| ANI Pharmaceuticals, Inc. | 6 | $151 |
| Novartis | 8 | $151 |
| AstraZeneca(2 entities) | 6 | $134 |
| Fresenius Kabi USA, LLC | 3 | $69 |
| GSK | 2 | $52 |
| Genentech USA, Inc. | 3 | $46 |
| UCB, Inc. | 2 | $42 |
| Lilly USA, LLC | 2 | $33 |
| Organon | 2 | $28 |
| Alvogen Inc | 1 | $23 |
| Boehringer Ingelheim | 1 | $21 |
| Sobi, Inc | 1 | $20 |
| Sanofi | 1 | $20 |
| Cumberland Pharmaceuticals, Inc. | 1 | $19 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
How this compares
$2,034 in reported general payments places this provider in the 25th percentile of 453 rheumatology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisone | 33 | $199 |
| Celecoxib | 11 | $171 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in Hollywood
- Mark JaffeHollywood$826K
- Rachel TateHollywood$729K
- Martha Hernandez IllasFort Lauderdale$25M
- Carlos SesinMiami Beach$19M
- Guillermo ValenzuelaPlantation$14.2M
- Marimer Rensoli VelazquezMiami$12.2M
- Robert LevinClearwater$11M
- Jigar ShahMargate$5.6M
- Michael BubbGainesville$3.3M
- Vipul JoshiBrandon$3.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.